Theravance Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $560.2M
Liabilities Breakdown FY2018
Total Liabilities: $611.8M
Asset Breakdown
Total Assets: $560.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $378.0M | 67.5% |
| Accounts Receivable | $620.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.2M | 2.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $168.4M | 30.1% |
Liabilities Breakdown
Total Liabilities: $611.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.0M | 1.5% |
| Long-Term Debt | $454.4M | 74.3% |
| Other Liabilities | $148.4M | 24.3% |